FR EN

Back


20/11/2018
Stilla Technologies completes a €16 Million funding round to commercialise its novel digital PCR system
Stilla Technologies, the European provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion of a Series A financing round of 16 million euros ($18 Million) led by Illumina Ventures with participation from  Idinvest Partners. 

Since 2016, Stilla Technologies has been providing research organisations specialised in molecular biology and genetic analysis with its Naica System, a ground-breaking digital PCR solution that enables scientists to detect and quantify DNA mutations with unrivalled precision.

Download the pdf file





X

X

X